Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
72
datasets available to search
ShareScore release 0.9.0
Dataset results
72 results for “primary myelofibrosis”
Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis
ClinicalTrials.gov study NCT04384692. IPD Sharing: NO. Countries: 1. Publications: 0.
Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis
ClinicalTrials.gov study NCT04370301. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Fedratinib in Japanese Subjects With DIPSS (Dynamic International Prognostic Scoring System)- Intermediate or High-risk Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (Po
ClinicalTrials.gov study NCT04446650. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase 2 Study in Japanese Patients With Intermediate-2 or High Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis With Splenomegaly
ClinicalTrials.gov study NCT01692366. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 Combined With Ruxolitinib in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Or Po
ClinicalTrials.gov study NCT04485260. IPD Sharing: Not stated. Countries: 9. Publications: 0.
Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis
ClinicalTrials.gov study NCT03426969. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Durvalumab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis
ClinicalTrials.gov study NCT02871323. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Assessment of Labile Plasma Iron (LPI) in Myelodysplastic Syndromes (MDS) and Primary Myelofibrosis
ClinicalTrials.gov study NCT01331603. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of LNK01002 in Patients With Primary or Secondary Myelofibrosis,Polycythemia Vera or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04896112. IPD Sharing: NO. Countries: 1. Publications: 0.
Defining the Molecular Risk in Israeli Patients With Secondary Compared to Primary Myelofibrosis
ClinicalTrials.gov study NCT03402399. IPD Sharing: NO. Countries: 1. Publications: 0.
Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera
ClinicalTrials.gov study NCT06516406. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Panobinostat and Ruxolitinib in Primary Myelofibrosis, Post-polycythemia Vera-myelofibrosis or Post-essential Thrombocythemia-myelofibrosis
ClinicalTrials.gov study NCT01433445. IPD Sharing: NO. Countries: 5. Publications: 0.
A Phase 1 Study of AJ1-11095 in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed
ClinicalTrials.gov study NCT06343805. IPD Sharing: NO. Countries: 1. Publications: 0.
Trial Ruxolitinib and Peg-interferon Alpha-2a Combination in Patients With Primary Myelofibrosis RUXOPeg
ClinicalTrials.gov study NCT02742324. IPD Sharing: YES. Countries: 1. Publications: 0.
Extension Study Evaluating the Long Term Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET)
ClinicalTrials.gov study NCT01236638. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Single-Cell ATAC+RNAseq from CD34+ cells of a Primary Myelofibrosis patient evolved to secondary Acute Myeloid Leukemia
GEO Series GSE221946. Homo sapiens. 4 samples. Type: Expression profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing.
Transcriptome analysis of bone marrow mesenchymal stromal cells from patients with Primary Myelofibrosis
GEO Series GSE44426. Homo sapiens. 12 samples. Type: Expression profiling by array.
DNA methylation in primary myelofibrosis is partly associated with driver mutations and distinct from other myeloid malignancies I
GEO Series GSE277841. Homo sapiens. 40 samples. Type: Methylation profiling by genome tiling array.
Short RNAs expression profiling in circulating CD34+ cells from Primary Myelofibrosis patients and from normal controls pooled bone marrow CD34+ cells.
GEO Series GSE69089. Homo sapiens. 6 samples. Type: Non-coding RNA profiling by high throughput sequencing.
Single cell genomic analysis of PBMCs cells from a primary myelofibrosis patient
GEO Series GSE251689. Homo sapiens. 1 samples. Type: Other.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.